News | SummitMD

POST-PCI raises red flags for routine functional testing in high-risk PCI patients

2-year follow-up of PCI patients at high anatomical, clinical risk showed no survival benefits with surveillance testing over standard care

News | AP VALVES & SH 2022

SAVR always better for younger AS? 'Durability data up to 10-years greenlights TAVR for patients between 65-70'

Long-term valve durability becomes crucial for younger AS populations; intermediate-term data strengthens case for TAVR in select patients under 70 years

News | AP VALVES & SH 2022

Data on TAVR-related stroke 'not enough, hard to justify routine EPD use except in BAV, ViVs,'

David J. Cohen, MD says field 'just not that good' at predicting TAVR-related stroke and its effects, but EPDs help patients with bicuspid valves, ViV procedures for now

News | AP VALVES & SH 2022

Not just alternative to SAVR: 'TAVR has become standard of treatment for severe, symptomatic AS'

AMC Heart Institute's Chairman Seung-jung Park, MD, PhD says 'For Tissue Valves, SAVR is Alternative to TAVR' in Severe, Symptomatic AS Patients Over 65 Years

News | AP VALVES & SH 2022

Promising new TAVR techniques, valves to realize ideal of '1 procedure, 1 valve' for life

Eberhard Grube, MD Addresses THV Newcomers, Caveats in Evolving Field of TAVR at AP VALVES & SH 2022

News | SummitMD

‘First big step’ for xenotransplantation inches forward elusive future of heart transplantation

Short-term success of 3 recent pig-to-human cardiac transplantations reignites drive to develop new treatment options for patients with heart failure, experts say

News | AP VALVES & SH 2022

Celebrating 2 decades of TAVI: How 1 inventor, pioneer pushed heart history forward

Renowned French physician, interventional cardiologist Alain G. Cribier recognizes advancements, achievements of 20-year TAVI journey at AP VALVES & SH 2022